Live feed07:45:00·2dPRReleasevia QuantisnowEuropean Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 InhibitorsByQuantisnow·Wall Street's wire, on your screen.GILD· Gilead Sciences Inc.Health Care
